- Home
- ZDGE vs DXR Comparison
ZDGE vs DXR Comparison
Compare ZDGE & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- DXR
- Stock Information
- Founded
- ZDGE 2008
- DXR 1970
- Country
- ZDGE United States
- DXR United States
- Employees
- ZDGE N/A
- DXR N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- DXR Medical/Dental Instruments
- Sector
- ZDGE Technology
- DXR Health Care
- Exchange
- ZDGE Nasdaq
- DXR Nasdaq
- Market Cap
- ZDGE 45.4M
- DXR 46.9M
- IPO Year
- ZDGE N/A
- DXR N/A
- Fundamental
- Price
- ZDGE $3.19
- DXR $11.00
- Analyst Decision
- ZDGE
- DXR Strong Buy
- Analyst Count
- ZDGE 0
- DXR 1
- Target Price
- ZDGE N/A
- DXR $25.00
- AVG Volume (30 Days)
- ZDGE 39.1K
- DXR 79.7K
- Earning Date
- ZDGE 06-12-2025
- DXR 01-01-0001
- Dividend Yield
- ZDGE N/A
- DXR N/A
- EPS Growth
- ZDGE N/A
- DXR 86.16
- EPS
- ZDGE N/A
- DXR 0.11
- Revenue
- ZDGE $29,511,000.00
- DXR $119,714.00
- Revenue This Year
- ZDGE N/A
- DXR N/A
- Revenue Next Year
- ZDGE $2.95
- DXR N/A
- P/E Ratio
- ZDGE N/A
- DXR $101.20
- Revenue Growth
- ZDGE 1.27
- DXR N/A
- 52 Week Low
- ZDGE $1.73
- DXR $6.55
- 52 Week High
- ZDGE $4.89
- DXR $11.38
- Technical
- Relative Strength Index (RSI)
- ZDGE 39.08
- DXR 59.56
- Support Level
- ZDGE $2.95
- DXR $10.01
- Resistance Level
- ZDGE $3.65
- DXR $11.02
- Average True Range (ATR)
- ZDGE 0.22
- DXR 0.68
- MACD
- ZDGE -0.06
- DXR 0.02
- Stochastic Oscillator
- ZDGE 24.22
- DXR 79.46
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.